Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protagonist Therapeutics

46.50
-1.7000-3.53%
Post-market: 46.500.00000.00%16:08 EDT
Volume:1.48M
Turnover:68.91M
Market Cap:2.85B
PE:10.99
High:47.25
Open:47.06
Low:45.79
Close:48.20
Loading ...
Mar 10, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 10, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 24, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 16, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 03, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 27, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Nov 20, 2019

Correspondence

[Cover]Correspondence
Nov 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 31, 2019

Major Issues Report

Current report, items 1.01, 2.03, and 3.03
Aug 08, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 08, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities